Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Actuate Therapeutics, Inc.

NASDAQ: ACTU · Life Sciences · 4 alerts · CIK 1652935

Share price
$0.2680Close, Nov 16
Market cap
$16.2M
Shares outstanding
60.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Actuate Therapeutics, Inc. filings on SEC EDGAR ↗

4:05 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Actuate Therapeutics Nasdaq/NYSE Compliance Notice

Actuate Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. This notice follows a separate July 2026 warning regarding the company's failure to meet the minimum market value of listed securities requirement.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.